Beam Therapeutics, Inc. (BEAM)
24.73
+1.08
(+4.57%)
USD |
NASDAQ |
Oct 15, 16:00
24.67
-0.06
(-0.24%)
After-Hours: 20:00
Beam Therapeutics Cash from Operations (TTM) : -359.38M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -359.38M |
| March 31, 2026 | -369.73M |
| December 31, 2025 | -345.10M |
| September 30, 2025 | -338.18M |
| June 30, 2025 | -344.82M |
| March 31, 2025 | -351.38M |
| December 31, 2024 | -347.25M |
| September 30, 2024 | -135.81M |
| June 30, 2024 | -137.47M |
| March 31, 2024 | -139.13M |
| December 31, 2023 | -149.20M |
| September 30, 2023 | -353.46M |
| June 30, 2023 | -338.17M |
| March 31, 2023 | -305.78M |
| Date | Value |
|---|---|
| December 31, 2022 | 22.53M |
| September 30, 2022 | 93.55M |
| June 30, 2022 | 171.05M |
| March 31, 2022 | 190.80M |
| December 31, 2021 | -66.27M |
| September 30, 2021 | -92.40M |
| June 30, 2021 | -116.62M |
| March 31, 2021 | -106.93M |
| December 31, 2020 | -95.74M |
| September 30, 2020 | -89.24M |
| June 30, 2020 | -85.02M |
| March 31, 2020 | -73.54M |
| December 31, 2019 | -72.00M |
| September 30, 2019 | -57.17M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Prime Medicine, Inc. | -156.05M |
| Intellia Therapeutics, Inc. | -346.64M |
| Twist Bioscience Corp. | -53.07M |
| Q32 Bio, Inc. | -19.83M |
| Sarepta Therapeutics, Inc. | 93.95M |